Literature DB >> 20020143

Prevalence of and risk factors for low bone mineral density in Japanese female patients with systemic lupus erythematosus.

Makio Furukawa1, Chikako Kiyohara, Hiroshi Tsukamoto, Hiroki Mitoma, Yasutaka Kimoto, Ayumi Uchino, Misato Nakagawa, Kensuke Oryoji, Terufumi Shimoda, Koichi Akashi, Mine Harada, Takahiko Horiuchi.   

Abstract

To examine the prevalence of and risk factors for low bone mineral density (BMD) (osteoporosis or osteopenia) in Japanese female patients with systemic lupus erythematosus (SLE). We performed BMD measurements by dual X-ray absorptiometry at the lumbar spine and the hip and collected basic and lifestyle-related, clinical and treatment characteristics among 58 SLE patients. Odds ratios (ORs) and their 95% confidence intervals (CIs) were assessed for associations between low BMD and selected factors among SLE patients. The mean BMD ± SD was 0.90 ± 0.17 g/cm(2) at the lumbar spine and 0.76 ± 0.17 g/cm(2) at the hip. The prevalence of osteopenia (2.5 SD < T score < 1 SD) was 50.0% and that of osteoporosis (T score < 2.5 SD) was 13.8% in our SLE patients. After adjustment for age and disease duration, we found the number of deliveries (OR = 5.58, 95% CI = 1.31-26.06; P = 0.02) to be a risk factor for overall low BMD (T score < 1 SD) and a maximal dosage of >50 mg/day of oral corticosteroids (OR = 0.25, 95% CI = 0.07-0.91; P = 0.035) as a preventive factor for low BMD at the lumbar spine. Reduced BMD, especially in spinal trabecular bone, was pronounced in Japanese female patients with SLE, particular in those with a history of delivery. A history of high-dose oral corticosteroids was associated with the preservation of BMD at the lumbar spine, however, further study is needed considering the limited sample size.

Entities:  

Mesh:

Year:  2009        PMID: 20020143     DOI: 10.1007/s00296-009-1244-5

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  41 in total

1.  Meta-analysis of walking for preservation of bone mineral density in postmenopausal women.

Authors:  Marrissa Martyn-St James; Sean Carroll
Journal:  Bone       Date:  2008-05-26       Impact factor: 4.398

2.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.

Authors:  M C Hochberg
Journal:  Arthritis Rheum       Date:  1997-09

Review 3.  Steroid osteoporosis.

Authors:  I R Reid
Journal:  Calcif Tissue Int       Date:  1989-08       Impact factor: 4.333

Review 4.  Glucocorticoid-induced osteoporosis: pathogenesis and management.

Authors:  B P Lukert; L G Raisz
Journal:  Ann Intern Med       Date:  1990-03-01       Impact factor: 25.391

5.  Use of single voided urine samples to estimate quantitative proteinuria.

Authors:  J M Ginsberg; B S Chang; R A Matarese; S Garella
Journal:  N Engl J Med       Date:  1983-12-22       Impact factor: 91.245

6.  A meta-analysis of cigarette smoking, bone mineral density and risk of hip fracture: recognition of a major effect.

Authors:  M R Law; A K Hackshaw
Journal:  BMJ       Date:  1997-10-04

7.  Bone mineral density in postmenopausal Chinese patients with systemic lupus erythematosus.

Authors:  C C Mok; A Mak; K M Ma
Journal:  Lupus       Date:  2005       Impact factor: 2.911

8.  Spontaneous production of bone-resorbing lymphokines by B cells in patients with systemic lupus erythematosus.

Authors:  Y Tanaka; K Watanabe; M Suzuki; K Saito; S Oda; H Suzuki; S Eto; U Yamashita
Journal:  J Clin Immunol       Date:  1989-09       Impact factor: 8.317

9.  Trends in the incidence and mortality of systemic lupus erythematosus, 1950-1992.

Authors:  K M Uramoto; C J Michet; J Thumboo; J Sunku; W M O'Fallon; S E Gabriel
Journal:  Arthritis Rheum       Date:  1999-01

10.  Fat mass is an important determinant of whole body bone density in premenopausal women but not in men.

Authors:  I R Reid; L D Plank; M C Evans
Journal:  J Clin Endocrinol Metab       Date:  1992-09       Impact factor: 5.958

View more
  4 in total

1.  Six-year follow-up study of bone mineral density in patients with systemic lupus erythematosus.

Authors:  J Jacobs; L-A Korswagen; A M Schilder; L H van Tuyl; B A C Dijkmans; W F Lems; A E Voskuyl; I E M Bultink
Journal:  Osteoporos Int       Date:  2012-10-03       Impact factor: 4.507

2.  Increased serum fibroblast growth factor-23 and decreased bone turnover in patients with systemic lupus erythematosus under treatment with cyclosporine and steroid but not steroid only.

Authors:  C-C Lai; W-S Chen; D-M Chang; Y-P Tsao; T-H Wu; C-T Chou; C-Y Tsai
Journal:  Osteoporos Int       Date:  2014-10-01       Impact factor: 4.507

3.  Prevalence and possible risk factors of low bone mineral density in untreated female patients with systemic lupus erythematosus.

Authors:  Yi-Ning Sun; Xiu-Yuan Feng; Lan He; Ling-Xia Zeng; Zhi-Ming Hao; Xiao-Hong Lv; Dan Pu
Journal:  Biomed Res Int       Date:  2015-02-11       Impact factor: 3.411

4.  Prevalence and Risk Factors of Reduced Bone Mineral Density in Systemic Lupus Erythematosus Patients: A Meta-Analysis.

Authors:  Jumei Xia; Ran Luo; Shuiming Guo; Yi Yang; Shuwang Ge; Gang Xu; Rui Zeng
Journal:  Biomed Res Int       Date:  2019-02-20       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.